RM
BIOA

Redpoint Management’s BioAge Labs BIOA Stock Holding History

Redpoint Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-383,254
Closed -$5.07M – 4
2025
Q4 		$5.07M Hold
383,254
– – 3.73% 2
2025
Q3 		$2.25M Hold
383,254
– – 1.36% 3
2025
Q2 		$1.58M Hold
383,254
– – 0.93% 3
2025
Q1 		$1.44M Sell
383,254
-1
-0% -$5 0.52% 4
2024
Q4 		$2.22M Hold
383,255
– – 0.7% 4
2024
Q3 		$7.97M Buy
+383,255
New +$7.68M 1.49% 5

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Redpoint Management's BIOA Position: Q1 2026 in Review

Redpoint Management sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 383,254 shares — an estimated $5.07M sold.

Redpoint Management first reported a position in BIOA in Q3 2024 and held it in 6 quarters. The position peaked at $7.97M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Redpoint Management reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Redpoint Management sold 383,254 BioAge Labs shares in Q1 2026, an estimated $5.07M.
  • Redpoint Management first reported a position in BioAge Labs in Q3 2024 and held it in 6 quarters.
  • Redpoint Management's BioAge Labs position peaked at $7.97M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Redpoint Management's 13F filing for Q1 2026, filed 15 May 2026.